Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
4,286,860
-
Shares change
-
+335,904
-
Total reported value, excl. options
-
$73,476,400
-
Value change
-
+$5,856,017
-
Number of buys
-
28
-
Number of sells
-
-24
-
Price
-
$17.17
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2021
73 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2021.
XBiotech Inc. - Common Shares, no par value (XBIT) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,286,860 shares
of 33,289,095 outstanding shares and own 12.88% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,357,575 shares), VANGUARD GROUP INC (743,590 shares), STATE STREET CORP (385,340 shares), GEODE CAPITAL MANAGEMENT, LLC (273,238 shares), WELLS FARGO & COMPANY/MN (227,517 shares), NORTHERN TRUST CORP (220,813 shares), Russell Investments Group, Ltd. (119,464 shares), CREDIT SUISSE AG/ (74,230 shares), Nuveen Asset Management, LLC (74,125 shares), and Bank of New York Mellon Corp (61,405 shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.